Journal of Medical Virology · 1985 · 53 citations · 9 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdverse Events Following ImmunizationVaccinationVaccine DevelopmentVaccine EffectivenessVaccine EfficacyVaccine SafetyBooster Dose EfficacyBooster Dose TimingComparative Vaccine SafetyHepatitis Virus VaccinationSerial SeroconversionSeroconversion RatesSerologic Response To Booster VaccinationVaccine-induced Antibody Responses
A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine. No allergic reactions were observed, and the rate of mild side effects was similar to the plasma-derived vaccine. Seroconversion rates in the first month were 60% (33/55) and 67% (37/55) with the 5-micrograms and 10-micrograms doses of the recombinant vaccine, respectively. All participants seroconverted by 3 months, and none lost antibody. These results are very similar to those for plasma-derived vaccine. Comparison of titres of antibody to hepatitis B surface antigen (anti-HBs) showed a slightly higher level with the 10-micrograms than with the 5-micrograms dose of the recombinant vaccine. Geometric mean titres of anti-HBs after the booster dose were similar in the 5-micrograms and 10-micrograms dose recombinant vaccine groups (2,620 and 2,748 IU/l, respectively) and in the 5-micrograms plasma-derived vaccine group (3,591 IU/l) but significantly higher (9,227 IU/l) with the 10-micrograms dose of the plasma-derived vaccine. These results confirm the safety and immunogenicity of the recombinant vaccine, although further study is needed on the duration of immunity.
9
W. Szmuness, Cladd E. Stevens, Edward J. Harley et al. · New England Journal of Medicine · 1980 · 1.1K citations
Human hepatitis B vaccine from recombinant yeast
W. J. McAleer, Eugene B. Buynak, Robert Z. Maigetter et al. · Nature · 1984 · 735 citations
Viral Hepatitis. 1981 International Symposium.
Annals of Internal Medicine · 1983 · 266 citations